Charles River Laboratories International, Inc. (CRL) stock analysis
In our weekly check, Charles River Laboratories International, Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 11 pass, warnings: 8, red flags: 5.
About Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NYSE as CRL.
What our checks show for CRL
Red flags
- Net debt is 9x a year of EBITDA (debt/equity 0.88). That limits room in a downturn and raises refinancing risk.
- The net margin fell by 10 points over 5 years, to 1%: the company keeps less of each sale as profit.
- The gross margin fell by 4.8 points, to 32.9%: costs are rising faster than prices.
- The net margin is only 1%: little room if costs rise.
- The stock has fallen as much as 78% from a peak. Would you have held through that?
Warning signs
- Analysts expect only about 3.6% a year of growth in revenue.
- Revenue grew only 0% a year over the last 3 years.
- Earnings per share fell 52.6% a year over the last 3 years.
- Net profit fell 56.4% a year over the last 3 years.
- The price swings a lot: 47.2% annual volatility. Expect large ups and downs.
- The stock is still below its previous peak.
- Beta 1.34: the stock usually moves more than the market, both up and down.
- Return on capital (ROCE) is only 8.8%.
Strengths
- Operating cash flow is 15.49x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 225% a year over the next years.
- Analysts expect the net margin to improve by 15.5 points from today's 1%.
- Free cash flow is 10% of revenue: cash for dividends, buybacks or growth.
- A large company: market value $16.19 billion.
Similar companies
RVTY · ICLR · MEDP · GH · QGEN · DGX
Questions
What grade does Charles River Laboratories International, Inc. (CRL) have?
In our weekly check, Charles River Laboratories International, Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 11 pass, warnings: 8, red flags: 5. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of CRL stock?
This week's biggest flags for Charles River Laboratories International, Inc.: High debt, Margins falling, Gross margin falling. In total 13 of 24 checks show a warning or a red flag.
What does Charles River Laboratories International, Inc. do?
Charles River Laboratories International, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NYSE as CRL.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis